Interim safety results from the East/South East (E/SE) Asian subgroup of the open-label TRUST (TaRceva lUng cancer Survival Treatment) study of erlotinib for advanced non-small-cell lung cancer (NSCLC).

Details

Language :

English

ISSN :

15560864

Volume :

2

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

115803982

Full Text :

https://doi.org/10.1097/01.JTO.0000283408.85001.f3